We are live on ! Find out more
CC

Corton Capital Portfolio holdings

AUM $40.7M
1-Year Est. Return 52.32%
This Fund
S&P 500
This Quarter Est. Return
+22.21%
1 Year Est. Return
+52.32%
3 Year Est. Return
+225.1%
5 Year Est. Return
10 Year Est. Return
AUM
$314M
AUM Growth
+$116M
Cap. Flow
+$68.6M
Cap. Flow %
21.84%
Top 10 Hldgs %
24.41%
Holding
668
New
255
Increased
199
Reduced
105
Closed
108

Sector Composition

Rank Sector Weight
1 Technology 35.4%
2 Healthcare 14.92%
3 Consumer Discretionary 9.96%
4 Financials 9.01%
5 Industrials 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOOF icon
551
Petco
WOOF
$797M
$90.1K 0.03%
28,502
-6,534
-19% -$22.6K
CTOS icon
552
Custom Truck One Source
CTOS
$2.31B
$85.7K 0.03%
+13,870
New +$81.8K
NPKI
553
NPK International
NPKI
$1.06B
$78.6K 0.03%
+11,839
New +$82.6K
PDSB icon
554
PDS Biotechnology
PDSB
$38.4M
$75.3K 0.02%
15,150
-6,941
-31% -$34.5K
CRBU icon
555
Caribou Biosciences
CRBU
$145M
$73.1K 0.02%
+12,749
New +$63K
CANO
556
DELISTED
Cano Health, Inc.
CANO
$71.1K 0.02%
+12,113
New +$143K
CNTY icon
557
Century Casinos
CNTY
$34M
$66.4K 0.02%
+13,599
New +$62.8K
EGRX
558
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$62.3K 0.02%
+11,917
New +$118K
SOND
559
DELISTED
Sonder
SOND
$58.1K 0.02%
+17,149
New +$99.1K
DSGN icon
560
Design Therapeutics
DSGN
$761M
$33.4K 0.01%
12,607
-14,527
-54% -$33.3K
AAL icon
561
American Airlines Group
AAL
$10.1B
-26,661
Closed -$342K
ABBV icon
562
AbbVie
ABBV
$443B
-2,157
Closed -$322K
ACRS icon
563
Aclaris Therapeutics
ACRS
$726M
-14,916
Closed -$102K
ADEA icon
564
Adeia
ADEA
$2.94B
-21,006
Closed -$224K
ALHC icon
565
Alignment Healthcare
ALHC
$3.07B
-36,074
Closed -$250K
ALLO icon
566
Allogene Therapeutics
ALLO
$649M
-12,628
Closed -$40K
ALT icon
567
Altimmune
ALT
$552M
-10,202
Closed -$26.5K
AMED
568
DELISTED
Amedisys
AMED
-2,261
Closed -$211K
ANGO icon
569
AngioDynamics
ANGO
$611M
-11,927
Closed -$87.2K
APLS
570
DELISTED
Apellis Pharmaceuticals
APLS
-6,083
Closed -$231K
ARHS icon
571
Arhaus
ARHS
$1.05B
-10,073
Closed -$93.7K
ARWR icon
572
Arrowhead Research
ARWR
$11.9B
-12,324
Closed -$331K
AWR icon
573
American States Water
AWR
$3.36B
-2,892
Closed -$228K
DCH
574
Dauch Corp
DCH
$1.34B
-21,151
Closed -$154K
AYI icon
575
Acuity Brands
AYI
$9.83B
-1,390
Closed -$237K

Similar funds

Corton Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Corton Capital held 668 positions worth $314M, up 59% from $198M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Corton Capital deployed $68.6M of net new capital in Q4 2023, opening 255 new positions and adding to 199 existing holdings. Its largest new stake was Merck: 14,809 shares worth $1.61M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was NextEra Energy, an estimated $959K trimmed.

  • Corton Capital's largest Q4 2023 buy was Merck: 14,809 shares worth $1.61M.
  • Corton Capital added most to Snowflake in Q4 2023, an estimated $861K increase.
  • Corton Capital's biggest Q4 2023 reduction was NextEra Energy, cutting an estimated $959K.
  • Corton Capital fully exited Mirati Therapeutics, Inc. Common Stock in Q4 2023, selling an estimated $971K.
  • Corton Capital's ten largest holdings make up 24% of its $314M portfolio in Q4 2023.
  • Corton Capital opened 255 new positions and closed 108 in Q4 2023.
  • Corton Capital's portfolio value rose 59% quarter-over-quarter to $314M.

Based on Corton Capital's 13F filing for Q4 2023, filed 14 Feb 2024.